جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

2 مُخرَج نتائج البحث عن «Intensive care»

نسخة أوليةمفتوح (مستودع)20221استشهاد

Secondary traumatic stress disorder among healthcare professionals working in high morbidity departments in Saudi Arabia: A cross-sectional survey

Research Square

Abstract Background: The purpose of this study was to evaluate secondary traumatic stress disorder among healthcare professionals (HCPs), particularly physiotherapists working in critical care, neurology, cardiology, pulmonology, and mental health departments in Saudi Arabia. This study highlights the prevalence of burnout and the level of stress endured by HCPs and identifies available preventive mechanisms to alleviate their emotional strain. Methods: A cross-sectional study was conducted from July 2021 to July 2022 in which healthcare workers, including physiotherapists from the critical care, emergency, neurology, cardiology, pulmonology, and mental health departments, were evaluated. The study collected data to measure secondary traumatic stress disorder among the participants. The Secondary Traumatic Stress Scale (STSS) was administered and analyzed using statistical tests. The prevalence of burnout, induced stress, and secondary traumatic stress were assessed. Results: A total of 78 healthcare workers were evaluated, of which 25.6% worked in the neurosurgery department and 11.5% work in the critical care and emergency departments. Among the participants, 28.2% worked more than 45 hours per week and 21.8% slept less than 5 hours per day. Of the healthcare workers, 12.8% suffered from severe stress, 52.6% suffered from moderate stress, and 28.2% suffered from mild stress. The three factors of the STSS were measured among the study subjects – the intrusion score (mean = 10.47), avoidance score (mean = 16.18), and arousal score (mean = 11.06) and their means were calculated accordingly. Conclusion: The study shows the need to implement a wide range of interventional programs to improve communication skills, reduce emotional distress, and implement relaxation activities in healthcare environments.

secondary traumatic stress disorderhealthcare workersphysiotherapistsburnout
نسخة أوليةمفتوح (مستودع)2020

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals: Retrospective Cohort Study

Research Square

Abstract Background: The uncertainty about COVID-19 outcomes in angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. The aim of this study was to determine the effect of ACEI/ARB use in patients with severe COVID-19. Methods: This retrospective cohort study was done in two Saudi public specialty hospitals designated as COVID-19 referral facilities. We included 354 patients with confirmed diagnosis of COVID-19 between April and June 2020, of which 146 were ACEI/ARB users and 208 were non-ACEI/ARB users. Controlling for confounders, we conducted a multivariate logistic regression and a sensitivity analyses using propensity score matching (PSM) and Inverse propensity score weighting (IPSW) for high risk patient subsets. Results: Compared to non-ACEI/ARB users, ACEI/ARB users had an eight-fold higher risk of developing critical or severe COVID-19 (OR=8.25, 95%CI=3.32-20.53); a nearly 7-fold higher risk of intensive care unit (ICU) admission (OR=6.76, 95%CI=2.88-15.89) and a nearly 5-fold higher risk of requiring noninvasive ventilation (OR=4.77,95%CI=2.15-10.55). Patients with diabetes, hypertension, and/or renal disease had a five-fold higher risk of severe COVID-19 disease (OR=5.40,95%CI=2.0-14.54]. These results were confirmed in the PSM and IPSW analyses. Conclusion: In general, but especially among patients with hypertension, diabetes, and/or renal disease, ACEI/ARB use is associated with a significantly higher risk of severe or critical COVID-19 disease, and ICU care.

COVID-19 pandemicACE inhibitorsangiotensin receptor blockerssevere COVID-19